Global Valvular Heart Disease Treatment Market Growth (Status and Outlook) 2025-2031
According to this study, the global Valvular Heart Disease Treatment market size will reach US$ million by 2031.
Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Valvular Heart Disease Treatment Industry Forecast” looks at past sales and reviews total world Valvular Heart Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Valvular Heart Disease Treatment sales for 2025 through 2031. With Valvular Heart Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valvular Heart Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Valvular Heart Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Valvular Heart Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Valvular Heart Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valvular Heart Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valvular Heart Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Valvular Heart Disease Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Valvular heart disease is characterized by damage to or a defect in one of the four heart valves namely the mitral valve, aortic valve, tricuspid valve, and pulmonary valve.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Valvular Heart Disease Treatment Industry Forecast” looks at past sales and reviews total world Valvular Heart Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Valvular Heart Disease Treatment sales for 2025 through 2031. With Valvular Heart Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Valvular Heart Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Valvular Heart Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Valvular Heart Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Valvular Heart Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Valvular Heart Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Valvular Heart Disease Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Valvular Heart Disease Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cardiac Catheterization
- Electrocardiogram (ECG)
- Chest X-Ray
- Stress Test
- Others
- Hospital & Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corp.
- Medtronic
- CryoLife Inc.
- Edwards Lifesciences Corporation
- LivaNova PLC
- Neovasc Inc.
- Micro Interventional Devices
- Symetis SA
- Jenavalve Technology
- TTK Healthcare Limited
- Colibri Heart Valve
- Lepu Medical Technology Co.
- Braile Biom?dica
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valvular Heart Disease Treatment Market Size (2020-2031)
2.1.2 Valvular Heart Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Valvular Heart Disease Treatment by Country/Region (2020, 2024 & 2031)
2.2 Valvular Heart Disease Treatment Segment by Type
2.2.1 Cardiac Catheterization
2.2.2 Electrocardiogram (ECG)
2.2.3 Chest X-Ray
2.2.4 Stress Test
2.2.5 Others
2.3 Valvular Heart Disease Treatment Market Size by Type
2.3.1 Valvular Heart Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
2.4 Valvular Heart Disease Treatment Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Ambulatory Surgical Centers
2.4.3 Research Institutes
2.5 Valvular Heart Disease Treatment Market Size by Application
2.5.1 Valvular Heart Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
3 VALVULAR HEART DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Valvular Heart Disease Treatment Market Size Market Share by Player
3.1.1 Global Valvular Heart Disease Treatment Revenue by Player (2020-2025)
3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Valvular Heart Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VALVULAR HEART DISEASE TREATMENT BY REGION
4.1 Valvular Heart Disease Treatment Market Size by Region (2020-2025)
4.2 Global Valvular Heart Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.4 APAC Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.5 Europe Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Valvular Heart Disease Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Valvular Heart Disease Treatment Market Size by Country (2020-2025)
5.2 Americas Valvular Heart Disease Treatment Market Size by Type (2020-2025)
5.3 Americas Valvular Heart Disease Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valvular Heart Disease Treatment Market Size by Region (2020-2025)
6.2 APAC Valvular Heart Disease Treatment Market Size by Type (2020-2025)
6.3 APAC Valvular Heart Disease Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Valvular Heart Disease Treatment Market Size by Country (2020-2025)
7.2 Europe Valvular Heart Disease Treatment Market Size by Type (2020-2025)
7.3 Europe Valvular Heart Disease Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valvular Heart Disease Treatment by Region (2020-2025)
8.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VALVULAR HEART DISEASE TREATMENT MARKET FORECAST
10.1 Global Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.1.1 Global Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.1.2 Americas Valvular Heart Disease Treatment Forecast
10.1.3 APAC Valvular Heart Disease Treatment Forecast
10.1.4 Europe Valvular Heart Disease Treatment Forecast
10.1.5 Middle East & Africa Valvular Heart Disease Treatment Forecast
10.2 Americas Valvular Heart Disease Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Valvular Heart Disease Treatment Forecast
10.2.2 Canada Market Valvular Heart Disease Treatment Forecast
10.2.3 Mexico Market Valvular Heart Disease Treatment Forecast
10.2.4 Brazil Market Valvular Heart Disease Treatment Forecast
10.3 APAC Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.3.1 China Valvular Heart Disease Treatment Market Forecast
10.3.2 Japan Market Valvular Heart Disease Treatment Forecast
10.3.3 Korea Market Valvular Heart Disease Treatment Forecast
10.3.4 Southeast Asia Market Valvular Heart Disease Treatment Forecast
10.3.5 India Market Valvular Heart Disease Treatment Forecast
10.3.6 Australia Market Valvular Heart Disease Treatment Forecast
10.4 Europe Valvular Heart Disease Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Valvular Heart Disease Treatment Forecast
10.4.2 France Market Valvular Heart Disease Treatment Forecast
10.4.3 UK Market Valvular Heart Disease Treatment Forecast
10.4.4 Italy Market Valvular Heart Disease Treatment Forecast
10.4.5 Russia Market Valvular Heart Disease Treatment Forecast
10.5 Middle East & Africa Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Valvular Heart Disease Treatment Forecast
10.5.2 South Africa Market Valvular Heart Disease Treatment Forecast
10.5.3 Israel Market Valvular Heart Disease Treatment Forecast
10.5.4 Turkey Market Valvular Heart Disease Treatment Forecast
10.6 Global Valvular Heart Disease Treatment Forecast by Type (2026-2031)
10.7 Global Valvular Heart Disease Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Valvular Heart Disease Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Valvular Heart Disease Treatment Product Offered
11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Information
11.2.2 B. Braun Melsungen AG Valvular Heart Disease Treatment Product Offered
11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 B. Braun Melsungen AG Main Business Overview
11.2.5 B. Braun Melsungen AG Latest Developments
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Information
11.3.2 Boston Scientific Corp. Valvular Heart Disease Treatment Product Offered
11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boston Scientific Corp. Main Business Overview
11.3.5 Boston Scientific Corp. Latest Developments
11.4 Medtronic
11.4.1 Medtronic Company Information
11.4.2 Medtronic Valvular Heart Disease Treatment Product Offered
11.4.3 Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Medtronic Main Business Overview
11.4.5 Medtronic Latest Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Information
11.5.2 CryoLife Inc. Valvular Heart Disease Treatment Product Offered
11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CryoLife Inc. Main Business Overview
11.5.5 CryoLife Inc. Latest Developments
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Information
11.6.2 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product Offered
11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Edwards Lifesciences Corporation Main Business Overview
11.6.5 Edwards Lifesciences Corporation Latest Developments
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Information
11.7.2 LivaNova PLC Valvular Heart Disease Treatment Product Offered
11.7.3 LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LivaNova PLC Main Business Overview
11.7.5 LivaNova PLC Latest Developments
11.8 Neovasc Inc.
11.8.1 Neovasc Inc. Company Information
11.8.2 Neovasc Inc. Valvular Heart Disease Treatment Product Offered
11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Neovasc Inc. Main Business Overview
11.8.5 Neovasc Inc. Latest Developments
11.9 Micro Interventional Devices
11.9.1 Micro Interventional Devices Company Information
11.9.2 Micro Interventional Devices Valvular Heart Disease Treatment Product Offered
11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Micro Interventional Devices Main Business Overview
11.9.5 Micro Interventional Devices Latest Developments
11.10 Symetis SA
11.10.1 Symetis SA Company Information
11.10.2 Symetis SA Valvular Heart Disease Treatment Product Offered
11.10.3 Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Symetis SA Main Business Overview
11.10.5 Symetis SA Latest Developments
11.11 Jenavalve Technology
11.11.1 Jenavalve Technology Company Information
11.11.2 Jenavalve Technology Valvular Heart Disease Treatment Product Offered
11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jenavalve Technology Main Business Overview
11.11.5 Jenavalve Technology Latest Developments
11.12 TTK Healthcare Limited
11.12.1 TTK Healthcare Limited Company Information
11.12.2 TTK Healthcare Limited Valvular Heart Disease Treatment Product Offered
11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 TTK Healthcare Limited Main Business Overview
11.12.5 TTK Healthcare Limited Latest Developments
11.13 Colibri Heart Valve
11.13.1 Colibri Heart Valve Company Information
11.13.2 Colibri Heart Valve Valvular Heart Disease Treatment Product Offered
11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Colibri Heart Valve Main Business Overview
11.13.5 Colibri Heart Valve Latest Developments
11.14 Lepu Medical Technology Co.
11.14.1 Lepu Medical Technology Co. Company Information
11.14.2 Lepu Medical Technology Co. Valvular Heart Disease Treatment Product Offered
11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Lepu Medical Technology Co. Main Business Overview
11.14.5 Lepu Medical Technology Co. Latest Developments
11.15 Braile Biom?dica
11.15.1 Braile Biom?dica Company Information
11.15.2 Braile Biom?dica Valvular Heart Disease Treatment Product Offered
11.15.3 Braile Biom?dica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Braile Biom?dica Main Business Overview
11.15.5 Braile Biom?dica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Valvular Heart Disease Treatment Market Size (2020-2031)
2.1.2 Valvular Heart Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Valvular Heart Disease Treatment by Country/Region (2020, 2024 & 2031)
2.2 Valvular Heart Disease Treatment Segment by Type
2.2.1 Cardiac Catheterization
2.2.2 Electrocardiogram (ECG)
2.2.3 Chest X-Ray
2.2.4 Stress Test
2.2.5 Others
2.3 Valvular Heart Disease Treatment Market Size by Type
2.3.1 Valvular Heart Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
2.4 Valvular Heart Disease Treatment Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Ambulatory Surgical Centers
2.4.3 Research Institutes
2.5 Valvular Heart Disease Treatment Market Size by Application
2.5.1 Valvular Heart Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
3 VALVULAR HEART DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Valvular Heart Disease Treatment Market Size Market Share by Player
3.1.1 Global Valvular Heart Disease Treatment Revenue by Player (2020-2025)
3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Valvular Heart Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VALVULAR HEART DISEASE TREATMENT BY REGION
4.1 Valvular Heart Disease Treatment Market Size by Region (2020-2025)
4.2 Global Valvular Heart Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.4 APAC Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.5 Europe Valvular Heart Disease Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Valvular Heart Disease Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Valvular Heart Disease Treatment Market Size by Country (2020-2025)
5.2 Americas Valvular Heart Disease Treatment Market Size by Type (2020-2025)
5.3 Americas Valvular Heart Disease Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Valvular Heart Disease Treatment Market Size by Region (2020-2025)
6.2 APAC Valvular Heart Disease Treatment Market Size by Type (2020-2025)
6.3 APAC Valvular Heart Disease Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Valvular Heart Disease Treatment Market Size by Country (2020-2025)
7.2 Europe Valvular Heart Disease Treatment Market Size by Type (2020-2025)
7.3 Europe Valvular Heart Disease Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Valvular Heart Disease Treatment by Region (2020-2025)
8.2 Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VALVULAR HEART DISEASE TREATMENT MARKET FORECAST
10.1 Global Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.1.1 Global Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.1.2 Americas Valvular Heart Disease Treatment Forecast
10.1.3 APAC Valvular Heart Disease Treatment Forecast
10.1.4 Europe Valvular Heart Disease Treatment Forecast
10.1.5 Middle East & Africa Valvular Heart Disease Treatment Forecast
10.2 Americas Valvular Heart Disease Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Valvular Heart Disease Treatment Forecast
10.2.2 Canada Market Valvular Heart Disease Treatment Forecast
10.2.3 Mexico Market Valvular Heart Disease Treatment Forecast
10.2.4 Brazil Market Valvular Heart Disease Treatment Forecast
10.3 APAC Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.3.1 China Valvular Heart Disease Treatment Market Forecast
10.3.2 Japan Market Valvular Heart Disease Treatment Forecast
10.3.3 Korea Market Valvular Heart Disease Treatment Forecast
10.3.4 Southeast Asia Market Valvular Heart Disease Treatment Forecast
10.3.5 India Market Valvular Heart Disease Treatment Forecast
10.3.6 Australia Market Valvular Heart Disease Treatment Forecast
10.4 Europe Valvular Heart Disease Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Valvular Heart Disease Treatment Forecast
10.4.2 France Market Valvular Heart Disease Treatment Forecast
10.4.3 UK Market Valvular Heart Disease Treatment Forecast
10.4.4 Italy Market Valvular Heart Disease Treatment Forecast
10.4.5 Russia Market Valvular Heart Disease Treatment Forecast
10.5 Middle East & Africa Valvular Heart Disease Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Valvular Heart Disease Treatment Forecast
10.5.2 South Africa Market Valvular Heart Disease Treatment Forecast
10.5.3 Israel Market Valvular Heart Disease Treatment Forecast
10.5.4 Turkey Market Valvular Heart Disease Treatment Forecast
10.6 Global Valvular Heart Disease Treatment Forecast by Type (2026-2031)
10.7 Global Valvular Heart Disease Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Valvular Heart Disease Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Valvular Heart Disease Treatment Product Offered
11.1.3 Abbott Laboratories Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Information
11.2.2 B. Braun Melsungen AG Valvular Heart Disease Treatment Product Offered
11.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 B. Braun Melsungen AG Main Business Overview
11.2.5 B. Braun Melsungen AG Latest Developments
11.3 Boston Scientific Corp.
11.3.1 Boston Scientific Corp. Company Information
11.3.2 Boston Scientific Corp. Valvular Heart Disease Treatment Product Offered
11.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Boston Scientific Corp. Main Business Overview
11.3.5 Boston Scientific Corp. Latest Developments
11.4 Medtronic
11.4.1 Medtronic Company Information
11.4.2 Medtronic Valvular Heart Disease Treatment Product Offered
11.4.3 Medtronic Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Medtronic Main Business Overview
11.4.5 Medtronic Latest Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Information
11.5.2 CryoLife Inc. Valvular Heart Disease Treatment Product Offered
11.5.3 CryoLife Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CryoLife Inc. Main Business Overview
11.5.5 CryoLife Inc. Latest Developments
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Information
11.6.2 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product Offered
11.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Edwards Lifesciences Corporation Main Business Overview
11.6.5 Edwards Lifesciences Corporation Latest Developments
11.7 LivaNova PLC
11.7.1 LivaNova PLC Company Information
11.7.2 LivaNova PLC Valvular Heart Disease Treatment Product Offered
11.7.3 LivaNova PLC Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 LivaNova PLC Main Business Overview
11.7.5 LivaNova PLC Latest Developments
11.8 Neovasc Inc.
11.8.1 Neovasc Inc. Company Information
11.8.2 Neovasc Inc. Valvular Heart Disease Treatment Product Offered
11.8.3 Neovasc Inc. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Neovasc Inc. Main Business Overview
11.8.5 Neovasc Inc. Latest Developments
11.9 Micro Interventional Devices
11.9.1 Micro Interventional Devices Company Information
11.9.2 Micro Interventional Devices Valvular Heart Disease Treatment Product Offered
11.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Micro Interventional Devices Main Business Overview
11.9.5 Micro Interventional Devices Latest Developments
11.10 Symetis SA
11.10.1 Symetis SA Company Information
11.10.2 Symetis SA Valvular Heart Disease Treatment Product Offered
11.10.3 Symetis SA Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Symetis SA Main Business Overview
11.10.5 Symetis SA Latest Developments
11.11 Jenavalve Technology
11.11.1 Jenavalve Technology Company Information
11.11.2 Jenavalve Technology Valvular Heart Disease Treatment Product Offered
11.11.3 Jenavalve Technology Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Jenavalve Technology Main Business Overview
11.11.5 Jenavalve Technology Latest Developments
11.12 TTK Healthcare Limited
11.12.1 TTK Healthcare Limited Company Information
11.12.2 TTK Healthcare Limited Valvular Heart Disease Treatment Product Offered
11.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 TTK Healthcare Limited Main Business Overview
11.12.5 TTK Healthcare Limited Latest Developments
11.13 Colibri Heart Valve
11.13.1 Colibri Heart Valve Company Information
11.13.2 Colibri Heart Valve Valvular Heart Disease Treatment Product Offered
11.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Colibri Heart Valve Main Business Overview
11.13.5 Colibri Heart Valve Latest Developments
11.14 Lepu Medical Technology Co.
11.14.1 Lepu Medical Technology Co. Company Information
11.14.2 Lepu Medical Technology Co. Valvular Heart Disease Treatment Product Offered
11.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Lepu Medical Technology Co. Main Business Overview
11.14.5 Lepu Medical Technology Co. Latest Developments
11.15 Braile Biom?dica
11.15.1 Braile Biom?dica Company Information
11.15.2 Braile Biom?dica Valvular Heart Disease Treatment Product Offered
11.15.3 Braile Biom?dica Valvular Heart Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Braile Biom?dica Main Business Overview
11.15.5 Braile Biom?dica Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Valvular Heart Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Valvular Heart Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cardiac Catheterization
Table 4. Major Players of Electrocardiogram (ECG)
Table 5. Major Players of Chest X-Ray
Table 6. Major Players of Stress Test
Table 7. Major Players of Others
Table 8. Valvular Heart Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Table 11. Valvular Heart Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Table 14. Global Valvular Heart Disease Treatment Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Valvular Heart Disease Treatment Revenue Market Share by Player (2020-2025)
Table 16. Valvular Heart Disease Treatment Key Players Head office and Products Offered
Table 17. Valvular Heart Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Table 22. Global Valvular Heart Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Valvular Heart Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Valvular Heart Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Valvular Heart Disease Treatment Market Size Market Share by Country (2020-2025)
Table 26. Americas Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Table 28. Americas Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Table 30. APAC Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Table 32. APAC Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Valvular Heart Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Valvular Heart Disease Treatment Market Size Market Share by Country (2020-2025)
Table 36. Europe Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Valvular Heart Disease Treatment
Table 42. Key Market Challenges & Risks of Valvular Heart Disease Treatment
Table 43. Key Industry Trends of Valvular Heart Disease Treatment
Table 44. Global Valvular Heart Disease Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Valvular Heart Disease Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Valvular Heart Disease Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Abbott Laboratories Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 49. Abbott Laboratories Valvular Heart Disease Treatment Product Offered
Table 50. Abbott Laboratories Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Abbott Laboratories Main Business
Table 52. Abbott Laboratories Latest Developments
Table 53. B. Braun Melsungen AG Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 54. B. Braun Melsungen AG Valvular Heart Disease Treatment Product Offered
Table 55. B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. B. Braun Melsungen AG Main Business
Table 57. B. Braun Melsungen AG Latest Developments
Table 58. Boston Scientific Corp. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 59. Boston Scientific Corp. Valvular Heart Disease Treatment Product Offered
Table 60. Boston Scientific Corp. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Boston Scientific Corp. Main Business
Table 62. Boston Scientific Corp. Latest Developments
Table 63. Medtronic Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 64. Medtronic Valvular Heart Disease Treatment Product Offered
Table 65. Medtronic Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Medtronic Main Business
Table 67. Medtronic Latest Developments
Table 68. CryoLife Inc. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 69. CryoLife Inc. Valvular Heart Disease Treatment Product Offered
Table 70. CryoLife Inc. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. CryoLife Inc. Main Business
Table 72. CryoLife Inc. Latest Developments
Table 73. Edwards Lifesciences Corporation Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 74. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product Offered
Table 75. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Edwards Lifesciences Corporation Main Business
Table 77. Edwards Lifesciences Corporation Latest Developments
Table 78. LivaNova PLC Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 79. LivaNova PLC Valvular Heart Disease Treatment Product Offered
Table 80. LivaNova PLC Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. LivaNova PLC Main Business
Table 82. LivaNova PLC Latest Developments
Table 83. Neovasc Inc. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 84. Neovasc Inc. Valvular Heart Disease Treatment Product Offered
Table 85. Neovasc Inc. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Neovasc Inc. Main Business
Table 87. Neovasc Inc. Latest Developments
Table 88. Micro Interventional Devices Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 89. Micro Interventional Devices Valvular Heart Disease Treatment Product Offered
Table 90. Micro Interventional Devices Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Micro Interventional Devices Main Business
Table 92. Micro Interventional Devices Latest Developments
Table 93. Symetis SA Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 94. Symetis SA Valvular Heart Disease Treatment Product Offered
Table 95. Symetis SA Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Symetis SA Main Business
Table 97. Symetis SA Latest Developments
Table 98. Jenavalve Technology Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 99. Jenavalve Technology Valvular Heart Disease Treatment Product Offered
Table 100. Jenavalve Technology Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Jenavalve Technology Main Business
Table 102. Jenavalve Technology Latest Developments
Table 103. TTK Healthcare Limited Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 104. TTK Healthcare Limited Valvular Heart Disease Treatment Product Offered
Table 105. TTK Healthcare Limited Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. TTK Healthcare Limited Main Business
Table 107. TTK Healthcare Limited Latest Developments
Table 108. Colibri Heart Valve Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 109. Colibri Heart Valve Valvular Heart Disease Treatment Product Offered
Table 110. Colibri Heart Valve Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Colibri Heart Valve Main Business
Table 112. Colibri Heart Valve Latest Developments
Table 113. Lepu Medical Technology Co. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 114. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product Offered
Table 115. Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Lepu Medical Technology Co. Main Business
Table 117. Lepu Medical Technology Co. Latest Developments
Table 118. Braile Biom?dica Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 119. Braile Biom?dica Valvular Heart Disease Treatment Product Offered
Table 120. Braile Biom?dica Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Braile Biom?dica Main Business
Table 122. Braile Biom?dica Latest Developments
Table 1. Valvular Heart Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Valvular Heart Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cardiac Catheterization
Table 4. Major Players of Electrocardiogram (ECG)
Table 5. Major Players of Chest X-Ray
Table 6. Major Players of Stress Test
Table 7. Major Players of Others
Table 8. Valvular Heart Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Table 11. Valvular Heart Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Table 14. Global Valvular Heart Disease Treatment Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Valvular Heart Disease Treatment Revenue Market Share by Player (2020-2025)
Table 16. Valvular Heart Disease Treatment Key Players Head office and Products Offered
Table 17. Valvular Heart Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Table 22. Global Valvular Heart Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Valvular Heart Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Valvular Heart Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Valvular Heart Disease Treatment Market Size Market Share by Country (2020-2025)
Table 26. Americas Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Table 28. Americas Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Table 30. APAC Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Table 32. APAC Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Valvular Heart Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Valvular Heart Disease Treatment Market Size Market Share by Country (2020-2025)
Table 36. Europe Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Valvular Heart Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Valvular Heart Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Valvular Heart Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Valvular Heart Disease Treatment
Table 42. Key Market Challenges & Risks of Valvular Heart Disease Treatment
Table 43. Key Industry Trends of Valvular Heart Disease Treatment
Table 44. Global Valvular Heart Disease Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Valvular Heart Disease Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Valvular Heart Disease Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Abbott Laboratories Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 49. Abbott Laboratories Valvular Heart Disease Treatment Product Offered
Table 50. Abbott Laboratories Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Abbott Laboratories Main Business
Table 52. Abbott Laboratories Latest Developments
Table 53. B. Braun Melsungen AG Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 54. B. Braun Melsungen AG Valvular Heart Disease Treatment Product Offered
Table 55. B. Braun Melsungen AG Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. B. Braun Melsungen AG Main Business
Table 57. B. Braun Melsungen AG Latest Developments
Table 58. Boston Scientific Corp. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 59. Boston Scientific Corp. Valvular Heart Disease Treatment Product Offered
Table 60. Boston Scientific Corp. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Boston Scientific Corp. Main Business
Table 62. Boston Scientific Corp. Latest Developments
Table 63. Medtronic Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 64. Medtronic Valvular Heart Disease Treatment Product Offered
Table 65. Medtronic Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Medtronic Main Business
Table 67. Medtronic Latest Developments
Table 68. CryoLife Inc. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 69. CryoLife Inc. Valvular Heart Disease Treatment Product Offered
Table 70. CryoLife Inc. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. CryoLife Inc. Main Business
Table 72. CryoLife Inc. Latest Developments
Table 73. Edwards Lifesciences Corporation Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 74. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Product Offered
Table 75. Edwards Lifesciences Corporation Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Edwards Lifesciences Corporation Main Business
Table 77. Edwards Lifesciences Corporation Latest Developments
Table 78. LivaNova PLC Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 79. LivaNova PLC Valvular Heart Disease Treatment Product Offered
Table 80. LivaNova PLC Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. LivaNova PLC Main Business
Table 82. LivaNova PLC Latest Developments
Table 83. Neovasc Inc. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 84. Neovasc Inc. Valvular Heart Disease Treatment Product Offered
Table 85. Neovasc Inc. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Neovasc Inc. Main Business
Table 87. Neovasc Inc. Latest Developments
Table 88. Micro Interventional Devices Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 89. Micro Interventional Devices Valvular Heart Disease Treatment Product Offered
Table 90. Micro Interventional Devices Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Micro Interventional Devices Main Business
Table 92. Micro Interventional Devices Latest Developments
Table 93. Symetis SA Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 94. Symetis SA Valvular Heart Disease Treatment Product Offered
Table 95. Symetis SA Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Symetis SA Main Business
Table 97. Symetis SA Latest Developments
Table 98. Jenavalve Technology Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 99. Jenavalve Technology Valvular Heart Disease Treatment Product Offered
Table 100. Jenavalve Technology Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Jenavalve Technology Main Business
Table 102. Jenavalve Technology Latest Developments
Table 103. TTK Healthcare Limited Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 104. TTK Healthcare Limited Valvular Heart Disease Treatment Product Offered
Table 105. TTK Healthcare Limited Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. TTK Healthcare Limited Main Business
Table 107. TTK Healthcare Limited Latest Developments
Table 108. Colibri Heart Valve Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 109. Colibri Heart Valve Valvular Heart Disease Treatment Product Offered
Table 110. Colibri Heart Valve Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Colibri Heart Valve Main Business
Table 112. Colibri Heart Valve Latest Developments
Table 113. Lepu Medical Technology Co. Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 114. Lepu Medical Technology Co. Valvular Heart Disease Treatment Product Offered
Table 115. Lepu Medical Technology Co. Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Lepu Medical Technology Co. Main Business
Table 117. Lepu Medical Technology Co. Latest Developments
Table 118. Braile Biom?dica Details, Company Type, Valvular Heart Disease Treatment Area Served and Its Competitors
Table 119. Braile Biom?dica Valvular Heart Disease Treatment Product Offered
Table 120. Braile Biom?dica Valvular Heart Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Braile Biom?dica Main Business
Table 122. Braile Biom?dica Latest Developments
LIST OF FIGURES
Figure 1. Valvular Heart Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Valvular Heart Disease Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Valvular Heart Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Valvular Heart Disease Treatment Sales Market Share by Country/Region (2024)
Figure 8. Valvular Heart Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Valvular Heart Disease Treatment Market Size Market Share by Type in 2024
Figure 10. Valvular Heart Disease Treatment in Hospital & Clinics
Figure 11. Global Valvular Heart Disease Treatment Market: Hospital & Clinics (2020-2025) & ($ millions)
Figure 12. Valvular Heart Disease Treatment in Ambulatory Surgical Centers
Figure 13. Global Valvular Heart Disease Treatment Market: Ambulatory Surgical Centers (2020-2025) & ($ millions)
Figure 14. Valvular Heart Disease Treatment in Research Institutes
Figure 15. Global Valvular Heart Disease Treatment Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Global Valvular Heart Disease Treatment Market Size Market Share by Application in 2024
Figure 17. Global Valvular Heart Disease Treatment Revenue Market Share by Player in 2024
Figure 18. Global Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Valvular Heart Disease Treatment Value Market Share by Country in 2024
Figure 24. United States Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Valvular Heart Disease Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Valvular Heart Disease Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 1. Valvular Heart Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Valvular Heart Disease Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Valvular Heart Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Valvular Heart Disease Treatment Sales Market Share by Country/Region (2024)
Figure 8. Valvular Heart Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Valvular Heart Disease Treatment Market Size Market Share by Type in 2024
Figure 10. Valvular Heart Disease Treatment in Hospital & Clinics
Figure 11. Global Valvular Heart Disease Treatment Market: Hospital & Clinics (2020-2025) & ($ millions)
Figure 12. Valvular Heart Disease Treatment in Ambulatory Surgical Centers
Figure 13. Global Valvular Heart Disease Treatment Market: Ambulatory Surgical Centers (2020-2025) & ($ millions)
Figure 14. Valvular Heart Disease Treatment in Research Institutes
Figure 15. Global Valvular Heart Disease Treatment Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Global Valvular Heart Disease Treatment Market Size Market Share by Application in 2024
Figure 17. Global Valvular Heart Disease Treatment Revenue Market Share by Player in 2024
Figure 18. Global Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Valvular Heart Disease Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Valvular Heart Disease Treatment Value Market Share by Country in 2024
Figure 24. United States Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Valvular Heart Disease Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Valvular Heart Disease Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Valvular Heart Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Valvular Heart Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Valvular Heart Disease Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Valvular Heart Disease Treatment Market Size 2026-2031 ($ millions)
More Publications
Global Valvular Heart Diseases Treatment Market Research and Forecast, 2018-2023
US$ 3,600.00
January 2019
-
Global Inflammatory Heart Disease Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
110 pages
Global Rheumatic Heart Disease Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
150 pages
Global Congenital Heart Disease Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
February 2022
112 pages
Global Congenital Heart Disease Treatment Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
111 pages
